Lessons Learned from Mapping the THIN Database to the Observational Medical Outcome Partnership (OMOP) Common Data Model (CDM)

Aug-10

AUTHORS : Xiaofeng Zhou, Epidemiology, Worldwide Safety and Regulatory, Pfizer Inc, 219 E. 42nd Street, Mail Stop 219/9/01, New York, NY, 10017, USA – Email: xiaofeng.zhou@pfizer.com

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 19(S1):311

DOI : 10.1002/pds.2019

Lessons Learned from Mapping the THIN Database to the Observational Medical Outcome Partnership (OMOP) Common Data Model (CDM)

More publications

Characteristics and Outcomes of Over a Million Patients with Infammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data Resource

Defining Mental Health Conditions Within Primary Care Data: A Validation Study With a Mixed Qualitative and Quantitative Approach

Trends in clinical workload in UK primary care 2005–2019: a retrospective cohort study